Free Trial

The Clorox Company (NYSE:CLX) Shares Sold by Asset Management One Co. Ltd.

Clorox logo with Consumer Staples background

Asset Management One Co. Ltd. trimmed its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 5.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 78,041 shares of the company's stock after selling 4,169 shares during the period. Asset Management One Co. Ltd. owned about 0.06% of Clorox worth $12,721,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its holdings in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter worth about $27,000. Continuum Advisory LLC grew its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC bought a new position in Clorox in the 3rd quarter worth about $48,000. Finally, Friedenthal Financial bought a new position in Clorox in the 3rd quarter worth about $49,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. Evercore ISI upped their target price on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research report on Wednesday, February 5th. DA Davidson lowered their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, Clorox has an average rating of "Hold" and an average price target of $158.21.

Get Our Latest Research Report on CLX

Clorox Stock Performance

Shares of NYSE CLX traded up $1.84 during midday trading on Thursday, reaching $152.93. The company had a trading volume of 1,382,160 shares, compared to its average volume of 1,322,812. The business's 50-day simple moving average is $158.11 and its 200 day simple moving average is $159.68. The stock has a market cap of $18.84 billion, a P/E ratio of 41.78, a P/E/G ratio of 2.54 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company earned $2.16 EPS. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines